NCT01223456 - Safety and Efficacy Study of ONGLYZA (Saxagliptin) Under Conditions of Actual Use | Biotech Hunter

Enrollment

542

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Type 2 Diabetes Mellitus

Trial Locations (11)

Research Site, Batangas

Research Site, Cebu City

Research Site, Davao City

Research Site, Iloilo City

Research Site, Las Piñas

Research Site, Makati

Research Site, Manila

Research Site, Pasig

Research Site, Quezon City

Research Site, Mabalacat

Research Site, Manila